HEPATITIS D, CHRONIC

Clinical trials for HEPATITIS D, CHRONIC explained in plain language.

Never miss a new study

Get alerted when new HEPATITIS D, CHRONIC trials appear

Sign up with your email to follow new studies for HEPATITIS D, CHRONIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 2 Completed 1

New hope for hepatitis d: experimental drug enters final testing phase

Disease control Not yet recruiting

This Phase 3 trial tests a drug called hepalatide (L47) in 150 people with chronic hepatitis D, a serious liver disease. Participants receive either the drug or a placebo daily for 48 weeks. The goal is to see if hepalatide can lower virus levels and normalize liver enzymes. Afte…

Matched conditions: HEPATITIS D, CHRONIC

Phase: PHASE3 • Sponsor: Shanghai HEP Pharmaceutical Co., Ltd. • Aim: Disease control

Last updated Jun 27, 2026 08:07 UTC

HEPATITIS D, CHRONIC

Get alerted when new HEPATITIS D, CHRONIC trials appear

New hope for hepatitis d: experimental drug enters final testing phase